Bot Image Develops AI-based Tool For Prostate Cancer Diagnosis

Bot Image, a United States MRI medical equipment firm, has acquired the US FDA’s (Food and Drug Administration) clearance for its ProstatID. The ProstatID is artificial intelligence (AI) software used in the diagnosis and detection of prostate cancer.

Meanwhile, Bot Image’s AI-driven CAD (Computer-aided driven) software has two major goals. They include accelerating and increasing the precision of prostate cancer detection (CADe) and diagnosis (CADx).

ProstatID Helps For Quick Detection Of Prostate Cancer 


Crypto Comeback Pro is the #1 cryptocurrency trading robot for investors! This trading tool has a %88 winning rate on trades and is the recommended trading software for cryptocurrency traders. Try The Trading Software For FREE Today. (Advertisement)


The ProstatID technology employs AI in conjunction with conventional MRI scanning to speed up and reduce the price of lesion detection. Also, the program of the tool recognizes and quantifies the prostate gland.

Afterward, it finds potential cancerous lesions and gives a likelihood of cancer to each of them. Additionally, it offers a PI-RADS (Prostate Imaging Reporting and Data System) score, which is a diagnostic case score.

Meanwhile, the company said it developed the algorithm by studying thousands of MRI image sets, pathology test data, guided biopsies, and radiological readings.

Furthermore, the tech firm claims that the program has helped save patients’ and practitioners’ time and finances. It was able to save lives via precise and early detection.

Also, ProstatID can partition a patient’s prostate and enhance the on-screen presentation of prostate MRI cases. Users can access the CAD tool, which is presently sold as a Software-as-a-Service (SaaS) product.

They must create a secure VPN tunnel between the cloud-based ProstatID server and the MRI system or radiology department server. The tool maintains data security using the software and connection, which both adhere to HIPAA rules.

Bot Image’s CEO Believes AI Can Solve Several Health Issues

According to Bot Image’s CEO, Dr. Randall Jones, there have been various pointers to the usefulness of AI for improving diagnosis. However, the adoption of prostate cancer screening and detection methods has not changed over the past 30 years. 

As a result, this has led to the death of countless men in the US. Jones said the ProstatID is encouraging development in the effort to save lives.

“With FDA approval, the adoption road is simple, and hospitals and radiological clinics may link in as little as one hour of IT work to start introducing this innovative technology to their patients,” Jones added.

Furthermore, radiologists can use the ProstatID product that offers secure, HIPAA-compliant communication between a facility’s radiology department server and the ProstatID server.


Crypto Comeback Pro is the #1 cryptocurrency trading robot for investors! This trading tool has a %88 winning rate on trades and is the recommended trading software for cryptocurrency traders. Try The Trading Software For FREE Today. (Advertisement)


Besides, the goal of Bot Image, Inc. is to combine AI with other diagnostic tools. This would allow for the enhancement of healthcare results where they matter most.


Chip Timing Global is not responsible for the content, accuracy, quality, advertising, products or any other content posted on the site. Some of the content on this site is paid content that is not written by our authors and the views expressed do not reflect the views of this website. Any disputes you may have with brands or companies mentioned in our content will need to be taken care of directly with the specific brands and companies. The responsibility of our readers who may click links in our content and ultimately sign up for that product or service is their own. Cryptocurrencies, NFTs and Crypto Tokens are all a high-risk asset, investing in them can lead to losses. Readers should do their own research before taking any action.


Leave a Reply

Your email address will not be published. Required fields are marked *

Chip Timing Global 2021 | All Rights Reserved | ✉ Contact | Disclaimer